SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Oncology Pharmacy Practice
This Article
Right arrow Full Text (OnlineFirst PDF)
Right arrow All Versions of this Article:
1078155209103657v1
1078155209103657v2    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Vila-Torres, E.
Right arrow Articles by Jimenez-Torres, NV.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vila-Torres, E.
Right arrow Articles by Jimenez-Torres, NV.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

Case report: cisplatin preparation error; patient management and morbidity

Elida Vila-Torres1*, Asuncion Albert-Mari2, Daniel Almenar-Cubells3, and NV. Jimenez-Torres2

1 Pharmacy Department, Hospital General de Ciudad Real, Ciudad Real, Spain
2 Pharmacy Department, University Hospital Dr Peset, Valencia, Spain, Department of Pharmacy and Pharmaceutics, University of Valencia, Spain
3 Oncology Unit, University Hospital Dr Peset, Valencia, Spain

* To whom correspondence should be addressed.


   Abstract

Introduction. Antineoplastic drug therapy errors represent a high iatrogenic potential due to antineoplastic drugs narrow therapeutic ranges and the complexity of chemotherapy regimens that may increase the risk of morbidity and mortality for oncology patients.

Setting. We report a 57-year-old man with head and neck cancer who mistakenly received 180 mg/m2 of cisplatin overdose despite the safety measures and validations carried out during preparation. The patient developed moderate nausea and vomiting, acute renal failure, hearing difficulty (tinnitus), and severe myelodepression.

Patient management. Prophylactic and symptomatic treatments were applied in order to prevent and correct toxicity during the 9 days stay at hospital.

Result. He recovered with mild tinnitus and mild renal impairment as the only sequelae. This case presents a hospital stay and treatment quite different to others used to reverse all cisplatin overdose toxicity and it shows the benefits of prompt management.

Key Words: Overdose; cisplatin; management; toxicity; medication error; morbidity

First published on March 20, 2009, doi:10.1177/1078155209103657
This version was published on August 26, 2009


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement